Author Geladaris, Anastasia

1 to 5 of 5 Items
  • 2021 | Journal Article | Research Paper | 
    ​ ​Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?​
    Geladaris, A.; Häusler, D. & Weber, M. S.​ (2021) 
    International Journal of Molecular Sciences, 22(7) pp. 3461​.​ DOI: https://doi.org/10.3390/ijms22073461 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?​
    Geladaris, A.; Torke, S. & Weber, M. S. ​ (2022) 
    CNS Drugs, 36(10) pp. 1019​-1030​.​ DOI: https://doi.org/10.1007/s40263-022-00951-z 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Bruton’s tyrosine kinase as a promising therapeutic target for multiple sclerosis​
    Saberi, D.; Geladaris, A.; Dybowski, S. & Weber, M. S.​ (2023) 
    Expert Opinion on Therapeutic Targets, 27(4-5) pp. 347​-359​.​ DOI: https://doi.org/10.1080/14728222.2023.2218615 
    ​Details  DOI 
  • 2023 | Journal Article | 
    ​ ​IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity​
    Geladaris, A.; Häusser-Kinzel, S.; Pretzsch, R.; Nissimov, N.; Lehmann-Horn, K.; Häusler, D. & Weber, M. S.​ (2023) 
    Acta Neuropathologica, 145(4) pp. 461​-477​.​ DOI: https://doi.org/10.1007/s00401-023-02552-6 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Toward identifying key mechanisms of progression in multiple sclerosis​
    Husseini, L.; Geladaris, A. & Weber, M. S.​ (2023) 
    Trends in Neurosciences,.​ DOI: https://doi.org/10.1016/j.tins.2023.11.005 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100